MICHAEL J. MARESCA M.D. NPI 1194893727

NPI Details

Michael J. Maresca, M.D. is a hematology and oncology internal medicine in Poughkeepsie, NY with 29 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Michael J. Maresca, M.D. NPI is 1194893727. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

19 BAKER AVE
SUITE 100
POUGHKEEPSIE, NY
ZIP 12601-359
Phone: (845) 454-1942
Fax: (845) 452-4638

The NPI 1194893727 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Uric acid level, blood (HCPCS:84550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more (HCPCS:99214)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (HCPCS:99233)
• Folic acid level, serum (HCPCS:82746)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg (HCPCS:Q5108)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (HCPCS:99232)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Protein measurement, serum (HCPCS:84165)
• Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more (HCPCS:99215)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Bilirubin level, direct (HCPCS:82248)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Red blood count, manual test (HCPCS:85044)
• Nephelometry, test method using light (HCPCS:83883)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more (HCPCS:99213)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes (HCPCS:99223)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, clotting time (HCPCS:85610)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Erythropoietin (protein) level (HCPCS:82668)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more (HCPCS:99205)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Drawing of blood for a medical problem (HCPCS:99195)
• Beta 2 glycoprotein 1 antibody (autoantibody) measurement (HCPCS:86146)
• Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
• Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
• Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Rheumatoid factor level (HCPCS:86431)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection of drug or substance into vein (HCPCS:96374)
• Ige (immune system protein) level (HCPCS:82785)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Screening test for autoimmune disorder (HCPCS:86038)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Testosterone (hormone) level, total (HCPCS:84403)
• Acute hepatitis panel (HCPCS:80074)

The enumeration date for this NPI number is 12/1/2006 and was last updated on 12/16/2009.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.